Shigeru Handa
Director @ AAIC Investment
Shigeru Handa is a Series A investor at AAIC Investment focused on Medical and Health Care. Shigeru Handa
- Total investments:
- 4
- Last investment:
- Lead investor:
- 50%
Last updated:
For AI agents: llms.txt
Industries Shigeru Handa invests in
Stages Shigeru Handa invests in
Countries Shigeru Handa invests in
Investment Focus
Industry
- Medical 3 (75%)
- Health Care 3 (75%)
- Hospital 1 (25%)
- Software 1 (25%)
- Psychology 1 (25%)
Stage
- Series A 2 (50%)
- Seed 1 (25%)
- Venture - Series Unknown 1 (25%)
Country
- Egypt 2 (50%)
- Kenya 1 (25%)
- Mauritius 1 (25%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Revital Healthcare
|
Revital Healthcare is a manufacturer of medical devices and disposables for hospitals and other medical laboratories. It offers single-use syringes, needles, re-use prevention syringes and auto-disable syringes which helps in reducing the transmission of HIV and other blood-borne diseases along with infusion sets, blood transfusion sets and bloodcollection tubesThe company was established in 2006 and is headquartered in Kilifi, Kenya. | $3M / Venture - Series Unknown / Dec 21, 2021 | |
Rology
|
AI-assisted On-demand Teleradiology Platform | Seed / Sep 14, 2020 | |
Shezlong
|
Shezlong is the first and largest online psychotherapy platform that aims to giving people convenient and private access to professional counseling in Arabic. Founded in 2016 with more than 350 therapists and 100 thousands clients. We primarily target Arab-speaking natives who are mostly allocated within the MENA region. However, Shezlong hasexperienced significant traction from Arabs all around the world, hitting 85 countries, and still growing exponentially!. Shezlong is the one-stop mental wellness shop that people seek to feel better. Starting from reading detailed and scientific blogs to get guidance, taking psychometric tests to assess their current state, receiving recommendations on the most relevant therapists for your case and booking a session, that's all Shezlong. We're with you 24x7, and we're part of our patients daily routine. And to do that, we empower therapists to become more successful and get closer to their patients! | Series A / Jun 07, 2020 | |
Africa Healthcare Network
|
Africa Healthcare Network (“AHN”) has established the first dialysis chain across Sub-Saharan Africa, providing high-quality, life-saving dialysis at affordable cost. AHN brings world-class technical expertise combined with developing world practical operating experience to a region in dire need of quality dialysis treatment. Dialysis is alife-saving treatment for patients with Acute Kidney Injury (AKI) and End-Stage Renal Disease (ESRD). The few hospitals that provide treatment operate centers that are slowly deteriorating while charging prohibitive prices. Additionally, the lack of trained professionals and limited capital investment in care for non-communicable diseases in Sub-Saharan Africa, dialysis centers are few and far between, causing patients to endure the high costs for travel to receive care. Those who cannot afford the costs of treatment and travel are resigned to death. Chronic Kidney Disease (CKD) and AKI are on the rise in the region due to strong epidemiologic factors, including increased urbanization leading to lifestyle diseases, other non-communicable diseases, HIV and other infections and toxins. Utilizing our network of executives/partners, we will secure high-quality equipment and train professionals to provide superior care. Our ability to source lowest cost consumables, operational efficiency and scale, will allow us to lower the cost to patients. The net result is increased access, higher quality and lower cost to patients, while maintaining profitability.AHN operates in Rwanda, Tanzania and Kenya. | Series A / Mar 17, 2019 |
Co-Investors
HIMAngel
2 deals together
Dubai Angel Investors
1 deal together
Ohara Pharmaceutical
1 deal together
About AAIC Investment
AAIC aims to invest in fast growing companies within the Healthcare sector in Africa. The focus will be to provide growth capital as well as long term value to assist companies in improving their performance and expansion.
AAIC Investment Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Shigeru Handa
Director
|
|||
|
Susumu Tsubaki
Chief Executive Officer & Director
|
|||
3 more contacts available
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Shigeru Handa invest in?
Shigeru Handa invests primarily in Medical, Health Care and Hospital startups, most often at Series A and Seed stage. Most of the 4 investments tracked by Shizune back companies in Egypt. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Shigeru Handa last invest?
The most recent investment recorded for Shigeru Handa closed in Dec 2021. Shizune tracks 4 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
